iiinova — where your digital self keeps evolving

Reposted by Dawn Hershman, MD, MS, FASCO

American Cancer Society @americancancersoc.bsky.social · 09/01/2026

3. A new @jamaoncology.com paper from ACS Professor @drdawnhershman.bsky.social & colleagues reporting patient-reported fatigue was associated w/ inc'd risk of cancer treatment-related toxic effects. Other ACS-funded authors include Dr. Joe Unger & Dr. Salene Jones. jamanetwork.com/journals/jam...

jamanetwork.com

Baseline Fatigue and Severe Toxic Effects in Patients With Cancer Receiving Systemic Therapy

This cohort study using data from randomized clinical trials evaluates the association of baseline patient-reported fatigue and the risk of toxic effects during subsequent cancer treatment.

111

Reposted by Dawn Hershman, MD, MS, FASCO

Columbia University @columbiauniversity.bsky.social · 23/08/2025

Columbia University's economic activity goes far beyond our campuses. Explore our contributions to science, technology, the arts, our city, our nation, and the world, since 1754: www.columbia.edu/content/tradition-…

Infographic stating Columbia University generates $12.6 billion in economic activity annually in New York, including over $10.7 billion in New York State. The background features a subtle graphic of a torch.

212

Reposted by Dawn Hershman, MD, MS, FASCO

SWOG Cancer Research Network @swog.org · 23/05/2025

Our @swog.org group chair's blog: SWOG at ASCO, 2025 Starting with @drdawnhershman.bsky.social's Karnofsky Science of Oncology Award Lecture in the opening session, the #ASCO25 Annual Meeting will feature some great work by SWOG researchers. www.swog.org/news-events/...

022

Reposted by Dawn Hershman, MD, MS, FASCO

American Society of Clinical Oncology @ascocancer.bsky.social · 08/05/2025

At #ASCO25, @drdawnhershman.bsky.social will be honored with the 2025 David A. Karnofsky Memorial Award for her work in advancing cancer outcomes for all patients. #ASCODailyNews has more on her career & accomplishments: brnw.ch/21wSvbq

083

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 18/03/2025

Thank you @nytimes.com for highlighting the impact of federal funding cuts on research & patient care. We share a common mission to improve the lives and wellbeing of others, and we share common values that everyone deserves the best care and treatment opportunities. www.nytimes.com/2025/03/18/n...

nytimes.com

Trump Cuts Imperil Cancer, Diabetes and Pediatric Research at Columbia

Dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative funding.

064

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 27/01/2025

I am profoundly grateful for this extraordinary honor 💗

3100

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 15/12/2024

Incredible accomplishment from our @swog.org 🫁 team. 👏👏👏

0103

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 11/12/2024

The best part of #SABCS24? Lunch with colleagues of course!

080

Reposted by Dawn Hershman, MD, MS, FASCO

Amylou Dueck, PhD @biostatgirl.bsky.social · 10/12/2024

Excited to see #PROCTCAE and #GP5 in the inavolisib label! Recurring points in the FDA discussion about needing dose optimization in early drug development to lower doses, maintain efficacy, and improve tolerability. Also comments about needing enrollment of diverse patients. #SABCS24

023

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 11/12/2024

Super important not to under-treat elderly women - as life expectancy may be quite high!

120

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 10/12/2024

Thank you all for your advocacy- I would just add - it is not just about measuring pro’s - it’s critically important to mitigate side effects early to help improve tolerance

000

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 10/12/2024

Such an important topic - so glad #SABCS24 included this in the program. More work needed to figure out how to include #PRO-cTCAE as an endpoint

071

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 08/12/2024

This @swog.org success story is only possible with #NCI federally funded research 🤞

052

Reposted by Dawn Hershman, MD, MS, FASCO

SWOG Cancer Research Network @swog.org · 06/12/2024

Our SWOG Group Chair blog: Modeling Adverse Event Risk Prediction: S2013 and S1501 Are Reopen to Enrollment! Two key trials by the SWOG #NCORP Research Base have reopened after temporary closures. Both trials are prime examples of public-powered research! www.swog.org/news-events/...

042

Reposted by Dawn Hershman, MD, MS, FASCO

SWOG Cancer Research Network @swog.org · 06/12/2024

#myeloMATCH is the NCI’s #precisionmedicine trial in #myeloid cancer: advanced biomarker testing in newly diagnosed acute myeloid #leukemia (#AML) or #myelodysplastic syndrome (#MDS) & treatment substudies by the Alliance, Canadian Cancer Trials Group, @eaonc.bsky.social & SWOG. swog.org/myeloMATCH

Advanced biomarker testing for adults with acute myeloid leukemia or myelodysplastic syndrome

0104

Reposted by Dawn Hershman, MD, MS, FASCO

Torie Bosch @thekibosch.bsky.social · 06/12/2024

"Because health insurance has become the face of both the rising premiums and the intrusive cost-containment efforts that are largely delegated to them, they have become the primary target of that anger. But it’s not just insurers," Elliott S. Fisher writes: www.statnews.com/2024/12/05/u...

statnews.com

Insurance companies like United Healthcare are not the only ones to blame for a broken system

The public response to United Healthcare CEO Brian Thompson’s murder misunderstands something important.

21714

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 05/12/2024

Congratulations @lynn_hershman for making the Art Review Power 100. 👏👏👏 artreview.com/power-100/

artreview.com

Power 100

031

Reposted by Dawn Hershman, MD, MS, FASCO

SWOG Cancer Research Network @swog.org · 03/12/2024

The S2312 trial in #mCRPC asks if adding carboplatin to cabazitaxel will significantly improve radiographic PFS in patients whose tumors are aggressive variant #prostatecancer (AVPC-MS) vs those whose tumors are not. PI: Paul Corn, MD, PhD, @mdanderson.bsky.social swog.org/clinical-trials/S2312

032

Reposted by Dawn Hershman, MD, MS, FASCO

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 03/12/2024

That's a wrap! Yesterday marked our final funding deadline of the year. We're busy reviewing, preparing for 2025, and excited for the next big questions we'll help @swog.org members to answer - thank you to our donors who make it all possible! #SWOGonc Upcoming opportunities: tinyurl.com/SWOG2025

tinyurl.com

The Hope Foundation Funding Opportunities - SWOG Cancer Research

The Hope Foundation funding opportunities provide fellowships and grants, educational programs, group meeting support, and development.

012

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 02/12/2024

Adherence is such big issue and such a challenging problem solve - we found the same thing in breast cancer patients taking endocrine therapy @swog.org study #S1105- pubmed.ncbi.nlm.nih.gov/32369401/ Lots of work needed to improve outcomes in patients who need oral therapies!!

096

Reposted by Dawn Hershman, MD, MS, FASCO

JAMA @jama.com · 01/12/2024

Many patients in the US struggle to afford their prescription drugs. This JAMA Patient Page outlines 7 strategies that patients can use to access medications at reduced cost. ja.ma/4g8HcZI

Strategies to Help Patients Afford Their Medicines in the US

63316

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 01/12/2024

30% of the patients with cancer in our practice endorse food insecurity!! Shocking but true. Thank you #HCWvsHunger #DiagnoseAndTreats for the inspiration and motivation to be part of this effort. 🙏

0217

Reposted by Dawn Hershman, MD, MS, FASCO

SWOG Cancer Research Network @swog.org · 30/11/2024

Just out in CCR from #DART #rarecancers trial: nivo/ipi can be effective in select non-epithelial #ovariancancer (granulosa cell tumor, ORR 25%, 1CR&1PR/8, >4 yrs). "SWOG/NCI Phase II Dual Anti–CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer" aacrjournals.org/clincancerre...

064

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 29/11/2024

Super excited to welcome Jason Zell as the new co-chair of the #SWOG #NCORP prevention committee 🎉 @supportingswog.bsky.social @swog.org

091

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 29/11/2024

We all know this is happening but seeing the data is mind blowing 🤯

010

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 25/11/2024

If you need a little inspiration this talk is soooo worth watching! ❤️

010

Dawn Hershman, MD, MS, FASCO @drdawnhershman.bsky.social · 24/11/2024

Very true - but I would not limit to immunotherapy- the financial issues for the multiple expanded indications for expensive oral therapies that are taken for years is a huge issue we need to address as a community- it’s not enough to show something works if the vast majority don’t have access. 🆘

070

Reposted by Dawn Hershman, MD, MS, FASCO

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 20/11/2024

Established in honor of the late SWOG leader Dr. Nicholas J. Vogelzang, the Vogelzang SWOG GU Scholarship supports early stage investigators' travel to 2 SWOG meetings & pairs them with a senior mentor. Applications for 2025 due January 15. Link in our latest email: conta.cc/3B0tI3n

063